16 - 19 November 2020, Düsseldorf, Germany.
OKRA, a Cambridge-based provider of Artificial Intelligence (AI) analytics for Life Sciences, has developed a new AI system to accurately predict the (a) price and (b) 'benefit outcome' of new drug molecules several years before launch. OKRA's system is the first of its kind and uses AI to deliver detailed evidence and reassurance to pharma professionals to aid the submission process, opening doors for more effective drugs to reach the market faster.
Mersey Care NHS Foundation Trust, one of the leading mental health and community health trusts in the country, launched a pilot of the 'COVID Oximetry@Home' service in April and began accepting referrals from primary care last month.
Smart health tech provider Alcidion Group Limited (ASX:ALC) has announced an expansion of its reseller agreement with NextGate to include the UK and Ireland.
In 2018, MKM Health (which was acquired by Alcidion in 2018) signed an agreement to resell NextGate's market leading Enterprise Master Patient Index (EMPI) and Provider Registry solutions in Australia and New Zealand.
Oxford Health NHS Foundation Trust is to implement an Electronic Prescribing and Medicines Administration (ePMA) solution called OPENeP from Better, working with CGI as implementation partner.
The trust is the second global digital exemplar providing mental health services to choose OPENeP as the result of an initiative to develop a procurement framework for open systems and platform technologies that was led by South London and Maudsley NHS Foundation Trust, where OPENeP is also currently being deployed.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced its participation in the RSNA 2020 virtual event, featuring its Radiology Workflow Suite of end-to-end solutions to drive operational and clinical efficiency through the digitalization, integration, and virtualization of radiology.
The COVID-19 pandemic has disrupted clinical operations and accelerated much-needed change, according to a new survey conducted by Informa Pharma Intelligence on behalf of Oracle Health Sciences. With patients unable to physically visit clinical trial sites, 76% of survey respondents noted that the pandemic sped their adoption of decentralized clinical trial methods.
Bayer will support five new startup companies as part of the company's G4A Digital Health Partnerships Program. Focus will be on fostering the development of a digital health ecosystem, while driving forward integrated healthcare solutions in the fields of cardiometabolic and renal diseases, oncology, and women's health. The participating digital healthcare companies were selected by Bayer from over 400 applications from over 65 countries based upon current and future strategic fit, development stage and assessment.